Publications:9
Accepting New Patients
- Treats Children & Adults
- Accepting New Patients
Daniel W Sherer, MD
Dermatology
No Patient Experience Ratings
Long Island Medical & Cosmetic Dermatology,PC516-433-3200
View all locationsAbout Me
Dr. Sherer is a board-certified dermatologist who has been in private practice on Long Island since 2003.
Dr. Sherer received his undergraduate degree from Tufts University and attended medical school at SUNY Downstate Medical College. He is a Fellow of the American Academy of Dermatology and has published over a dozen original articles in professional journals.
Dr. Sherer trained at the Mount Sinai School of Medicine where he completed his residency and Dermatopharmacology fellowship. He was awarded First Prize and a grant from the National Institute of Health for his research leading to a potential treatment of a connective tissue disease called Pseudoxanthoma Elasticum.
Dr. Sherer remains on staff at Mount Sinai as an Assistant Clinical Professor where he teaches both dermatology residents and medical students.
In our practice, we treat all medical conditions that affect the skin, such as acne, rosacea, atopic dermatitis (eczema), psoriasis and warts. Dr. Sherer is skilled at screening for and treating skin cancers such as Basal Cell Carcinoma, Squamous Cell Carcinoma, and the most serious form of skin cancer: Melanoma.
As a dermatologist, Dr. Sherer is also an expert in treating conditions such as Herpes Zoster (Shingles), pigmentary disorders such as Melasma, and diseases of the hair and nails such as alopecia areata and onychomycosis.
Language
English
Position
ASSISTANT CLINICAL PROFESSOR | Dermatology
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Education
MD, SUNY Downstate Health Sciences University - College of Medicine
Internship, Internal Medicine
Staten Island University Hospital
Residency, Dermatology
Icahn School of Medicine At Mount Sinai
Fellowship, Clinical Pharmacology
Icahn School of Medicine At Mount Sinai
Certifications
American Board of Dermatology
Awards
2002
First Prize
New York Academy of Medicine Resident Research Competition
Research
Principal Investigator - Psoriasis Study - Genetics Institute, 1998-1999
Principal Investigator - Acne Study - Allergan, 1998-1999
Principal Investigator - Photoaging Study - Johnson & Johnson (Skin Types I-III), 1998-2000
Principal Investigator - Photoaging Study - Johnson & Johnson (Skin Types IV-VI)
Principal Investigator - Acne Study - Allergan, 1998-1999
Principal Investigator - Photoaging Study - Johnson & Johnson (Skin Types I-III), 1998-2000
Principal Investigator - Photoaging Study - Johnson & Johnson (Skin Types IV-VI)
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Oral phosphate binders in the treatment of pseudoxanthoma elasticum. Daniel W. Sherer, Giselle Singer, Jaime Uribarri, Robert G. Phelps, Allen N. Sapadin, K. Bailey Freund, Lawrence Yanuzzi, Wayne Fuchs, Mark Lebwohl. Journal of the American Academy of Dermatology
- Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. Nicholas Lowe, Steven R. Feldman, Daniel Sherer, Jonathan Weiss, Joel S. Shavin, Yin Lui Lin, Valerie Foley, Pascale Soto. Journal of Dermatological Treatment
- Long-Term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: A two-year, randomized, placebo-controlled trial. Sewon Kang, Wilma Bergfeld, Alice B. Gottlieb, Janet Hickman, John Humeniuk, Steven Kempers, Mark Lebwohl, Nicholas Lowe, Amy McMichael, James Milbauer, Tania Phillips, Jerold Powers, David Rodriguez, Ronald Savin, Joel Shavin, Daniel Sherer, Nancy Silvis, Richard Weinstein, Jonathan Weiss, Craig Hammerberg, Gary J. Fisher, Marge Nighland, Rachel Grossman, Judit Nyirady. American Journal of Clinical Dermatology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sherer has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.